Galena Biopharma Inc. (GALE) Drops 29.02% on January 07

Equities Staff |

Galena Biopharma Inc. (GALE) was one of the Russell 2000's biggest losers for Thursday January 07 as the stock slid 29.02% to $0.92, a loss of $-0.3743 per share. Starting at an opening price of $1.08 a share, the stock traded between $0.88 and $1.08 over the course of the trading day. Volume was 10.47 million shares over 20,180 trades, against an average daily volume of 1.17 million shares and a total float of 161.91 million.

The losses send Galena Biopharma Inc. down to a market cap of $148.26 million. In the last year, Galena Biopharma Inc. has traded between $2.39 and $1.10, and its 50-day SMA is currently $1.54 and 200-day SMA is $1.59.

Galena Biopharma Inc, is a biopharmaceutical company focused on developing and commercializing targeted oncology therapeutics that address medical needs across the full spectrum of cancer care.

Galena Biopharma Inc. is based out of Portland, OR and has some 57 employees. Its CEO is Mark W. Schwartz.

For a complete fundamental analysis analysis of Galena Biopharma Inc., check out Equities.com’s Stock Valuation Analysis report for GALE. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

IBC Advanced Alloys Corp.

IBC Advanced Alloys Corp is engaged in the production and development of specialty alloy products. Its products include copper alloys and berryllium aluminium alloys.

Private Markets

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…